Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:123:1-473.
doi: 10.1007/978-3-031-42422-9_1.

Neurotrophic Natural Products

Affiliations

Neurotrophic Natural Products

Yoshiyasu Fukuyama et al. Prog Chem Org Nat Prod. 2024.

Abstract

Neurotrophins (NGF, BDNF, NT3, NT4) can decrease cell death, induce differentiation, as well as sustain the structure and function of neurons, which make them promising therapeutic agents for the treatment of neurodegenerative disorders. However, neurotrophins have not been very effective in clinical trials mostly because they cannot pass through the blood-brain barrier owing to being high-molecular-weight proteins. Thus, neurotrophin-mimic small molecules, which stimulate the synthesis of endogenous neurotrophins or enhance neurotrophic actions, may serve as promising alternatives to neurotrophins. Small-molecular-weight natural products, which have been used in dietary functional foods or in traditional medicines over the course of human history, have a great potential for the development of new therapeutic agents against neurodegenerative diseases such as Alzheimer's disease. In this contribution, a variety of natural products possessing neurotrophic properties such as neurogenesis, neurite outgrowth promotion (neuritogenesis), and neuroprotection are described, and a focus is made on the chemistry and biology of several neurotrophic natural products.

Keywords: Chemical synthesis; Natural products; Neurite outgrowth; Neurogenesis; Neuroprotective; Neurotrophic activity; Neurotrophin; Neurotrophin mimetics; PC12 cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Data from Welfare White Paper, 2018 edn. https://www.mhlw.go.jp/wp/hakusyo/kousei/19/dl/1-01.pdf
    1. Thompson LM (2008) Neurodegeneration: a question of balance. Nature 452:707 - PubMed - DOI
    1. Data from Dementia Policy Promotion Comprehensive (New Orange Plan) (2018). https://www.mhlw.go.jp/content/000522832.pdf
    1. Querfurth HW, Lafera FM (2010) Alzheimer’s disease. N Engl J Med 362:329 - PubMed - DOI
    1. Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430:631 - PubMed - PMC - DOI

LinkOut - more resources